Significant growth in Covid-19 testing combined with gradual recovery in pathology services and entry into the sexual health testing market has boosted revenue at Integrated Pathology Partnerships (iPP). The Synlabs-owned company, which provides pathology services to the NHS and independent sector, reported a 45% jump in turnover to £14.3m in the year ended 31 December…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
.){kind=link}